MedPath

LITHIZINE CAP 150MG

LITHIZINE CAP 150MG

Discontinued
DIN Number

00328782

Drug Class

Human

Market Date

Dec 31, 1975

Company
HC

labs maney paul labs, division of 471449 (ont) ltee/ltd.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number00328782
AIG Number0101163001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
N05AN01 LITHIUM
Product Specifications
Dosage FormCapsule
Route of AdministrationOral
AHFS Classification28:28.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

LITHIUM CARBONATEActive
Strength: 150 MG / CAP
Monograph: LITHIUM CARBONATE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.